ARTICLE | Company News
Oxagen, Cerylid deal
September 4, 2001 7:00 AM UTC
The companies will combine their genetic studies on endometriosis to discover genes and polymorphisms that influence susceptibility to endometriosis and deliver targets from which diagnostics and trea...